The Business Times
business-time-50

Global pharma firms interested in local startup's new glaucoma treatment

google-preferred-sourceAdd BT as a preferred source
Published Tue, Dec 9, 2014 · 09:50 PM

    Singapore

    "FIRST you have my interest, now you have my attention."

    And that is what local biotech startup Peregrine Ophthalmic managed to do, in the words of associate professor Tina Wong, who was describing how a new glaucoma drug delivery solution developed by her 15-month-old startup has attracted inquiries from the world's top five pharmaceutical companies.

    TRENDING NOW

    Norris Road in Little India. An operator of unlicensed money remittance services for migrant workers was sentenced to jail recently.

    A ‘shadow bank’ hiding in Singapore’s Little India casts light on financial services gap

    Grant Wee built Hideaway as a massage-and-bathhouse concept centred on solitude and recovery.

    UOB CEO’s youngest child Grant Wee turns burnout into a wellness business

    For H1 2026, Seatrium’s net profit jumped 158.3% year on year to S$372.9 million.

    Can Seatrium build on its robust H1 earnings? UOBKH and DBS analysts have divided views

    Yeoh Pei Xien is the youngest grandchild of Yeoh Tiong Lay, who founded Malaysian multinational conglomerate YTL Corporation.

    Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More